Oncology Medical News about CML

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Leukemia and Lymphoma, 07/02/09

Mascarenhas CC et al. - D-HPLC is a practical and sensitive method for routine clinical monitoring for emergence of kinase domain mutations and may be useful for optimising therapy in CML. The screening of mutations in exon 6 is clinically relevant, once the presence of mutations confers a poor outcome. Early detection of emerging mutant clones may help in decision-making for alternative treatment.

<< Previous
Miltenberger blood group antigen type III (Mi.III) enhances the...

Next >>
Analysis of the Ten-Eleven Translocation (TET)2 gene in familial...

Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia
Blood, 11/13/09 Relevance Score: 87%

BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients
European Journal of Haematology, 11/04/09 Relevance Score: 87%

Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
Blood, 10/30/09 Relevance Score: 87%

Epidemiological study on survival of chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) patients with BCR-ABL T315I mutation
Blood, 11/06/09 Relevance Score: 84%

Outcome of 125 children with CML who received transplants from unrelated donors: the Japan Marrow Donor Program (JMDP)
Biology of Blood and Marrow Transplantation, 10/07/09 Relevance Score: 84%